Artykuły w czasopismach na temat „HNSC CANCER TREATMENT”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „HNSC CANCER TREATMENT”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Agee, Robert, Samuel Flashner, Masataka Shimonosono, Andres Klein-Szanto i Hiroshi Nakagawa. "Abstract 3082: Leveraging 3D organoids to identify molecular changes underlying HNSC initiation and development". Cancer Research 82, nr 12_Supplement (15.06.2022): 3082. http://dx.doi.org/10.1158/1538-7445.am2022-3082.
Pełny tekst źródłaBurkart, Sebastian, Christopher Weusthof, Karam Khorani, Sonja Steen, Fabian Stögbauer, Kristian Unger, Julia Hess i in. "A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment". Cancers 15, nr 6 (8.03.2023): 1655. http://dx.doi.org/10.3390/cancers15061655.
Pełny tekst źródłaZhao, Yixuan, Xin Huang, Zewei Zhang, Haizhou Li i Tao Zan. "The Long Noncoding Transcript HNSCAT1 Activates KRT80 and Triggers Therapeutic Efficacy in Head and Neck Squamous Cell Carcinoma". Oxidative Medicine and Cellular Longevity 2022 (4.08.2022): 1–19. http://dx.doi.org/10.1155/2022/4156966.
Pełny tekst źródłaTang, Shouyi, Li Zhao, Xing-Bo Wu, Zhen Wang, Lu-Yao Cai, Dan Pan, Ying Li, Yu Zhou i Yingqiang Shen. "Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas". Cancers 14, nr 16 (18.08.2022): 3986. http://dx.doi.org/10.3390/cancers14163986.
Pełny tekst źródłaPradhan, Sultan, i Arsheed Hussain Hakeem. "Management of Head and Neck Cancer: Surgical and Nonsurgical". An International Journal of Otorhinolaryngology Clinics 2, nr 1 (2010): 77–85. http://dx.doi.org/10.5005/jp-journals-10003-1020.
Pełny tekst źródłaChen, Yin-Ju, Joseph T. Chang, Guo-Rung You, Chun-Yu Huang, Kang-Hsing Fan i Ann-Joy Cheng. "Panel biomarkers associated with cancer invasion and prognostic prediction for head–neck cancer". Biomarkers in Medicine 15, nr 11 (sierpień 2021): 861–77. http://dx.doi.org/10.2217/bmm-2021-0213.
Pełny tekst źródłaChuang, Yi-Hsuan, Chun-Yu Lin, Jih-Chin Lee, Chia-Hwa Lee, Chia-Lin Liu, Sing-Han Huang, Jung-Yu Lee, Wen-Sen Lai i Jinn-Moon Yang. "Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer". International Journal of Molecular Sciences 24, nr 17 (22.08.2023): 13068. http://dx.doi.org/10.3390/ijms241713068.
Pełny tekst źródłaPark, Jun-Ook, Young Min Park, Woo-Jin Jeong, Yoo Seob Shin, Yong Tae Hong, Ik Joon Choi, Ji Won Kim i in. "Survival Benefits From Surgery for Stage IVa Head and Neck Squamous Cell Carcinoma: A Multi-Institutional Analysis of 1,033 Cases". Clinical and Experimental Otorhinolaryngology 14, nr 2 (1.05.2021): 225–34. http://dx.doi.org/10.21053/ceo.2020.01732.
Pełny tekst źródłaXu, Chengbo, Hongfang Xu i Baimei Liu. "Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes". PeerJ 11 (21.11.2023): e16364. http://dx.doi.org/10.7717/peerj.16364.
Pełny tekst źródłaHill, James H., Randall L. Plant, David M. Harris i Randal C. Paniello. "Photodynamic Therapy for Head and Neck Cancer Xenografts in Athymic Mice". Otolaryngology–Head and Neck Surgery 95, nr 5 (grudzień 1986): 602–6. http://dx.doi.org/10.1177/019459988609500515.
Pełny tekst źródłaFekete, János Tibor, Ágnes Welker i Balázs Győrffy. "miRNA Expression Signatures of Therapy Response in Squamous Cell Carcinomas". Cancers 13, nr 1 (28.12.2020): 63. http://dx.doi.org/10.3390/cancers13010063.
Pełny tekst źródłaGrau, J. J., M. Caballero, E. Verger i J. L. Blanch. "Actual proportion of patients (pts) receiving chemotherapy or cetuximab for head and neck squamous carcinoma (HNSC)". Journal of Clinical Oncology 27, nr 15_suppl (20.05.2009): e17058-e17058. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e17058.
Pełny tekst źródłaBaulch, Janet E., Munjal M. Acharya, Barrett D. Allen, Ning Ru, Nicole N. Chmielewski, Vahan Martirosian, Erich Giedzinski i in. "Cranial grafting of stem cell-derived microvesicles improves cognition and reduces neuropathology in the irradiated brain". Proceedings of the National Academy of Sciences 113, nr 17 (4.04.2016): 4836–41. http://dx.doi.org/10.1073/pnas.1521668113.
Pełny tekst źródłaZewde, Makda Getachew, Daniel Fulop, Alexander Tsankov i Kuan-lin Huang. "Abstract A47: Characterization of immune cell composition across cancer types in pan-cancer genomic cohorts". Cancer Immunology Research 10, nr 12_Supplement (1.12.2022): A47. http://dx.doi.org/10.1158/2326-6074.tumimm22-a47.
Pełny tekst źródłaYang, Linhui, Zhiwei Chen, Yunliang Liu, Xiaoyan Wang, Jing Li i Qing Ye. "Immunization Combined with Ferroptosis Related Genes to Construct a New Prognostic Model for Head and Neck Squamous Cell Carcinoma". Cancers 14, nr 17 (24.08.2022): 4099. http://dx.doi.org/10.3390/cancers14174099.
Pełny tekst źródłaErdim, Ibrahim. "Parotidectomy in head-neck skin cancers: Our clinical experience". Praxis of Otorhinolaryngology 10, nr 3 (27.10.2022): 101–9. http://dx.doi.org/10.5606/kbbu.2022.88262.
Pełny tekst źródłaKim, Nari, Mi-Hyun Kim, Junhee Pyo, Soo-Min Lee, Ji-Sung Jang, Do-Wan Lee i Kyung Won Kim. "CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications". Biomedicines 11, nr 11 (27.10.2023): 2910. http://dx.doi.org/10.3390/biomedicines11112910.
Pełny tekst źródłaMadan, Sanna, Sanju Sinha, Alejandro A. Schäffer i Eytan Ruppin. "Abstract LB062: Identifying novel targets for CAR-T therapies from single cell RNA-sequencing data". Cancer Research 83, nr 8_Supplement (14.04.2023): LB062. http://dx.doi.org/10.1158/1538-7445.am2023-lb062.
Pełny tekst źródłaLi, Yuan, Jiagen Li, Nan Sun, Mei Luo, Chengcheng Zhou, Xuejiao Shi, Wenhui Yang, Zhiliang Lu, Zhaoli Chen i Jie He. "Identification and functional characterization of long noncoding RNA NMR as biomarker for metastasis and prognosis in esophageal squamous cell carcinoma." Journal of Clinical Oncology 35, nr 15_suppl (20.05.2017): e15587-e15587. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e15587.
Pełny tekst źródłaAcharya, Munjal M., Lori-Ann Christie, Thomas G. Hazel, Karl K. Johe i Charles L. Limoli. "Transplantation of Human Fetal-Derived Neural Stem Cells Improves Cognitive Function following Cranial Irradiation". Cell Transplantation 23, nr 10 (październik 2014): 1255–66. http://dx.doi.org/10.3727/096368913x670200.
Pełny tekst źródłaLee, Suyeon, Heewon Jung, Jiwoo Park i Jaegyoon Ahn. "Accurate Prediction of Cancer Prognosis by Exploiting Patient-Specific Cancer Driver Genes". International Journal of Molecular Sciences 24, nr 7 (29.03.2023): 6445. http://dx.doi.org/10.3390/ijms24076445.
Pełny tekst źródłaKholod, Olha, William Basket, Danlu Liu, Jonathan Mitchem, Jussuf Kaifi, Laura Dooley i Chi-Ren Shyu. "Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene". Cancers 14, nr 19 (29.09.2022): 4759. http://dx.doi.org/10.3390/cancers14194759.
Pełny tekst źródłaLv, Ran, Fang Lv, Pei Zhihua, Jianing Yu, Xiuyu Zhao, Yiqian Liu, Yaxi Zhang, Geng Chen, Weizhi Chen i Ji He. "Noninvasive detection of chromosomal instability in plasma circulating cell-free DNA for early pan-cancer diagnosis using low-pass whole-genome sequencing." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): e22509-e22509. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e22509.
Pełny tekst źródłaKoenigs, Maria B., Armida Lefranc-Torres, Juliana Bonilla-Velez, Krupal B. Patel, D. Neil Hayes, Krzysztof Glomski, Paul M. Busse i in. "Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy". JNCI: Journal of the National Cancer Institute 111, nr 9 (31.01.2019): 933–42. http://dx.doi.org/10.1093/jnci/djy224.
Pełny tekst źródłaLiu, Jinhui, Yuanyuan Wang, Jian Yin, Yan Yang, Rui Geng, Zihang Zhong, Senmiao Ni i in. "Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy". Journal of Oncology 2022 (12.01.2022): 1–21. http://dx.doi.org/10.1155/2022/3477148.
Pełny tekst źródłaWu, Sheng, Xiangkang Lv, Yilin Li, Xinyi Gao, Zhiqi Ma, Xiao Fu i Yong Li. "Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma". Journal of Oncology 2022 (1.09.2022): 1–12. http://dx.doi.org/10.1155/2022/3140263.
Pełny tekst źródłaMahmoud, Yamil Damian, Florencia Veigas, Joaquin Merlo, Monica Balzarini, Dario Rocha, Gabriel Adrian Rabinovich, Elmer Fernandez i Maria Romina Romina Girotti. "Bioinformatic profiling of tumor immunity from patient biopsies to predict survival and response to immunotherapy." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e15198-e15198. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e15198.
Pełny tekst źródłaCirillo, Nicola, Carmen Wu i Stephen S. Prime. "Heterogeneity of Cancer Stem Cells in Tumorigenesis, Metastasis, and Resistance to Antineoplastic Treatment of Head and Neck Tumours". Cells 10, nr 11 (8.11.2021): 3068. http://dx.doi.org/10.3390/cells10113068.
Pełny tekst źródłaPrince, Mark E. P., i Laurie E. Ailles. "Cancer Stem Cells in Head and Neck Squamous Cell Cancer". Journal of Clinical Oncology 26, nr 17 (10.06.2008): 2871–75. http://dx.doi.org/10.1200/jco.2007.15.1613.
Pełny tekst źródłaAnurag, Meenakshi, Eric Jaehnig, Jonathan Lei, Beom-Jun Kim, Anh Minh Tran Huynh, Yongchao Dou, Tanmayi Vashist i in. "Abstract 1010: LIG1 deletion predicts chemotherapy resistance, chromosomal instability, and poor prognosis in triple negative breast cancer". Cancer Research 82, nr 12_Supplement (15.06.2022): 1010. http://dx.doi.org/10.1158/1538-7445.am2022-1010.
Pełny tekst źródłaSchmidt, Henri, Arutha Kulasinghe, Richard Allcock, Lit Tan, Elisa Mokany, Liz Kenny i Chamindie Punyadeera. "A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer". Diagnostics 8, nr 4 (29.11.2018): 79. http://dx.doi.org/10.3390/diagnostics8040079.
Pełny tekst źródłaShah, Amit, Shilpa Patel, Jigna Pathak, Niharika Swain i Shwetha Kumar. "The Evolving Concepts of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma". Scientific World Journal 2014 (2014): 1–8. http://dx.doi.org/10.1155/2014/842491.
Pełny tekst źródłaHidy, Samantha, i David Weaver. "230 Single cell PIK3 gene expression patterns support duvelisib (PI3K-delta, gamma inhibitor) treatment of melanoma and other tumors after checkpoint inhibitor therapy". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (listopad 2020): A248. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0230.
Pełny tekst źródłaJavaid, Sehrish, Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon, Da'Jhnae Gambrell-Sanders i in. "Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma". Molecular Cancer Therapeutics 21, nr 5 (28.02.2022): 762–74. http://dx.doi.org/10.1158/1535-7163.mct-21-0142.
Pełny tekst źródłaSarnella, Annachiara, Ylenia Ferrara, Luigi Auletta, Sandra Albanese, Vincenzo Alterio, Jean-Yves Winum, Claudiu T. Supuran, Laura Cerchia, Giuseppina De Simone i Antonella Zannetti. "Abstract 1040: Blocking hypoxia-induced carbonic anhydrases 9 enhances sensibility to cisplatin of head and neck squamous carcinoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 1040. http://dx.doi.org/10.1158/1538-7445.am2022-1040.
Pełny tekst źródłaPorcheri, Cristina, i Thimios A. Mitsiadis. "New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas". Cancers 13, nr 21 (3.11.2021): 5515. http://dx.doi.org/10.3390/cancers13215515.
Pełny tekst źródłaCruz-Gregorio, Alfredo, Imelda Martínez-Ramírez, José Pedraza-Chaverri i Marcela Lizano. "Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma". Cancers 11, nr 2 (5.02.2019): 182. http://dx.doi.org/10.3390/cancers11020182.
Pełny tekst źródłaKrishnatry, Rahul, Tejpal Gupta, Vedang Murthy, Sudhir Vasudevan Nair, Deepa Nair, Pankaj Chaturvedi, A. K. Dcruz i in. "Distant metastasis in head and neck cancer: Baseline factors." Journal of Clinical Oncology 30, nr 15_suppl (20.05.2012): e16021-e16021. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e16021.
Pełny tekst źródłaMiari, Reem, Naiel Azzam, Rinat Bar-Shalom i Fuad Fares. "5-aza-2’-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line". PLOS ONE 16, nr 9 (17.09.2021): e0253756. http://dx.doi.org/10.1371/journal.pone.0253756.
Pełny tekst źródłaPillai, Sangeeth, Jan C. Kwan, Fares Yaziji, Hanwen Yu i Simon D. Tran. "Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers". Cancers 15, nr 15 (31.07.2023): 3894. http://dx.doi.org/10.3390/cancers15153894.
Pełny tekst źródłaSingh, Khushwant, i Pramod kumar Gautam. "Emulating the Role of Neutrophils in Head and Neck Cancer Microenvironment: Prognostic Role and Therapeutic Strategies". Journal of Cancer Immunology 5, nr 2 (28.08.2023): 61–73. http://dx.doi.org/10.33696/cancerimmunol.5.076.
Pełny tekst źródłaXia, Yu, Xiuqin Li i Wei Sun. "Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China". Current Gene Therapy 20, nr 2 (18.09.2020): 127–41. http://dx.doi.org/10.2174/1566523220999200731003206.
Pełny tekst źródłaShrestha, Gambhir, Bhola Siwakoti, Rashmi Mulmi i Dejkumar Gautam. "Trend of Head and Neck Cancers in a National Tertiary Cancer Hospital of Nepal from 2012 to 2017". South Asian Journal of Cancer 10, nr 04 (grudzień 2021): 236–40. http://dx.doi.org/10.1055/s-0041-1731131.
Pełny tekst źródłaKong, Lingyi, i Andrew C. Birkeland. "Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges". Cancers 13, nr 8 (14.04.2021): 1874. http://dx.doi.org/10.3390/cancers13081874.
Pełny tekst źródłaLiu, Xiqiang, Zugen Chen, Jinsheng Yu, James Xia i Xiaofeng Zhou. "MicroRNA Profiling and Head and Neck Cancer". Comparative and Functional Genomics 2009 (2009): 1–11. http://dx.doi.org/10.1155/2009/837514.
Pełny tekst źródłaBejenaru, Paula Luiza, Bogdan Popescu, Alina Lavinia Antoaneta Oancea, Catrinel Beatrice Simion-Antonie, Gloria Simona Berteșteanu, Mihnea Condeescu-Cojocarița, Anca Ionela Cîrstea i in. "Quality-of-Life Assessment after Head and Neck Oncological Surgery for Advanced-Stage Tumours". Journal of Clinical Medicine 11, nr 16 (19.08.2022): 4875. http://dx.doi.org/10.3390/jcm11164875.
Pełny tekst źródłaMeliante, Piero Giuseppe, Carla Petrella, Marco Fiore, Antonio Minni i Christian Barbato. "Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention". Antioxidants 12, nr 9 (12.09.2023): 1753. http://dx.doi.org/10.3390/antiox12091753.
Pełny tekst źródłaRühle, Alexander, Anca-Ligia Grosu i Nils H. Nicolay. "De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond". Cancers 13, nr 9 (4.05.2021): 2204. http://dx.doi.org/10.3390/cancers13092204.
Pełny tekst źródłaKuo, Selena Z., Christine O. Honda, Wei Tse Li, Thomas K. Honda, Elizabeth Kim, Xabier Altuna, Eric Abhold, Jessica Wang-Rodriguez i Weg M. Ongkeko. "Metformin Results in Diametrically Opposed Effects by Targeting Non-Stem Cancer Cells but Protecting Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma". International Journal of Molecular Sciences 20, nr 1 (7.01.2019): 193. http://dx.doi.org/10.3390/ijms20010193.
Pełny tekst źródłaAllevato, Michael, Yumi Yokoyama, Robert Wild i J. Silvio Gutkind. "Abstract 3027: Elucidating the role of glutamine metabolism in head & neck squamous cell carcinoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 3027. http://dx.doi.org/10.1158/1538-7445.am2022-3027.
Pełny tekst źródła